JTC Employer Solutions Trustee’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-500
Closed -$27K 315
2025
Q3
$27K Hold
500
﹤0.01% 267
2025
Q2
$27K Hold
500
﹤0.01% 255
2025
Q1
$22K Hold
500
﹤0.01% 270
2024
Q4
$28K Hold
500
﹤0.01% 267
2024
Q3
$34K Hold
500
﹤0.01% 260
2024
Q2
$21K Hold
500
﹤0.01% 279
2024
Q1
$33K Hold
500
﹤0.01% 273
2023
Q4
$38K Hold
500
﹤0.01% 267
2023
Q3
$34K Hold
500
﹤0.01% 276
2023
Q2
$47K Hold
500
﹤0.01% 267
2023
Q1
$34K Hold
500
﹤0.01% 291
2022
Q4
$25K Hold
500
﹤0.01% 307
2022
Q3
$16K Hold
500
﹤0.01% 266
2022
Q2
$20K Hold
500
﹤0.01% 237
2022
Q1
$35K Hold
500
﹤0.01% 229
2021
Q4
$39K Hold
500
﹤0.01% 225
2021
Q3
$48K Hold
500
0.01% 221
2021
Q2
$62K Buy
+500
New +$59.7K 0.01% 197

Other funds holding EXAS

JTC Employer Solutions Trustee's EXAS Position: Q4 2025 in Review

JTC Employer Solutions Trustee sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 500 shares — an estimated $27K sold.

JTC Employer Solutions Trustee first reported a position in EXAS in Q2 2021 and held it in 18 quarters. The position peaked at $62K in Q2 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • JTC Employer Solutions Trustee reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • JTC Employer Solutions Trustee sold 500 Exact Sciences shares in Q4 2025, an estimated $27K.
  • JTC Employer Solutions Trustee first reported a position in Exact Sciences in Q2 2021 and held it in 18 quarters.
  • JTC Employer Solutions Trustee's Exact Sciences position peaked at $62K in Q2 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on JTC Employer Solutions Trustee's 13F filing for Q4 2025, filed 10 Feb 2026.